Research News

- Read more about Janssen present New Phase 3 Data In Treatment of Moderate to Severe Plaque Psoriasis
Janssen Research & Development, LLC (Janssen) announced findings from the first of three pivotal Phase 3 studies evaluating guselkumab, a subcutaneously administered anti-interleukin (IL)-23 monoclonal antibody in late-stage development for the treatment of adults with moderate to severe plaque psoriasis.
- Read more about Sanofi Pasteur received approval for Dengvaxia® dengue vaccine
Sanofi Pasteur, the vaccines global business unit of Sanofi, announced Dengvaxia® dengue vaccine has now received its 11th marketing approval, four of which granted from Regulatory Authorities recognized by the World Health Organization (WHO). To date the vaccine is approved in Mexico, The Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore.
- Read more about Life saving drug, D-Penicillamine is not availble in indian market
Life saving drug (D-Penicillamine) is not available across India. And CDSCO working faster on availability of drug in the market.
- Read more about Cancer Research UK, MSD and Verastem Collaborate to Trial New Combination of Immunotherapy Drugs
MSD, Verastem, Inc. and Cancer Research UK will trial a new combination of immunotherapy drugs in mesothelioma, non small cell lung and pancreatic cancers. The trial will run through the ECMC network at centres in Edinburgh-Dundee, Southampton, Glasgow, Leicester and Belfast.

[adsense:336x280:8701650588]
- Read more about Nanobiomed Inc® Discovered a New Nuclear Staining Molecule and Eco-Friendly Natural Source for Cancer Diagnostics: Prextrolin®
Nanobiomed Inc®., a nanomedicine and biotechnology company announced its leading-edge development of a new molecule for use in tissue and cancer diagnostics.
- Read more about Administering additional antibiotic prior to C-section reduces infection rates by 50%
“Infection during pregnancy and during the postpregnancy period is a major health problem for both mom and baby, and a common underlying cause of death,” said Alan T. N. Tita, M.D., Ph.D.; professor in the UAB Division of Maternal-Fetal Medicine and the Center for Women’s Reproductive Health, and principal investigator of the study. “Women who have a C-section are at significantly increased risk for infection compared to those who deliver vaginally. A major national goal is to reduce the risk of infection after surgery, and this finding is the culmination of investigative work over decades.”
- Read more about Omega-3 fatty acid called DHA, can stop a known trigger of lupus
A team of Michigan State University researchers has found that consuming an omega-3 fatty acid called DHA, or docosahexaenoic acid, can stop a known trigger of lupus and potentially other autoimmune disorders.
- Read more about Research into fly development provides insights into blood vessel formation
Researchers working with flies at IRB Barcelona describe that the concentration of some small intracellular organelles determines the branching capacity of tracheal cells. Tracheal cells are analogous to the cells that form blood vessels in the human body. The inhibition or stimulation of new blood vessels has implications in cancer and in tissue regeneration.
- Read more about Tuberculosis Could be controlled by vitamin D
Research in Veterinary Science reveals that vitamin D supplementation reduces the incidence and severity of tuberculosis (TB) in wild boar and red deer. The pilot study of 40 animals was conducted by a multidisciplinary team of scientists from the University of Surrey (UK), Universidad de Extremadura (Spain), and SME Ingulados (Spain).
- Read more about Some Herbal and Dietary Supplements Can Be Toxic to the Live
A new review based on a research symposium sponsored by the American Association for the Study of Liver Disease and the National Institutes of Health highlights the potentially damaging effects of herbal and dietary supplements (HDSs) on the liver.